Top 20 of Migraine Disorders

Article title # Publications/# Citations

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.

1996: DEBulman; MFerrari; MDFerrari; RRFrants; JHaan; SMHoffman; MHHofker; JELamerdin; ... DLindhout; HWMohrenweiser; PJOefner; RAOphoff; GMTerwindt; Rvan Eijk; GJvan Ommen; MNVergouwe;

173

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

2001 Jul-Aug: MLDiamond; SDiamond; RBLipton; MReed; WFStewart;

144

Migraine--current understanding and treatment.

2002: MDFerrari; PJGoadsby; RBLipton;

124

Migraine prevalence, disease burden, and the need for preventive therapy.

2007: AMPP Advisory Group; MEBigal; MDiamond; FFreitag; RBLipton; MLReed; WFStewart;

119

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.

2007: CABlum; DNCortright; SREid; ASzallasi;

105

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.

2002: DABoas; HBolay; AKDunn; ZHuang; MAMoskowitz; UReuter;

99

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

2004: BIBN 4096 BS Clinical Proof of Concept Study Group; HCDiener; PJGoadsby; DHall; IWHusstedt; LMLesko; UMeier; JOlesen; SPollentier;

97

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.

1990: LEdvinsson; REkman; PJGoadsby;

90

New appendix criteria open for a broader concept of chronic migraine.

2006: Headache Classification Committee; MGBousser; HCDiener; DDodick; MFirst; PJGoadsby; HGöbel; MJLainez; ... JWLance; RBLipton; GNappi; JOlesen; FSakai; JSchoenen; SDSilberstein; TJSteiner;

89

High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.

1996: CGyldensted; KKKwong; LOstergaard; BRRosen; AGSorensen; RMWeisskoff;

80

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.

1992: DDCelentano; RBLipton; MLReed; WFStewart;

78

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

1993: LEdvinsson; PJGoadsby;

76

Pathophysiology of the migraine aura. The spreading depression theory.

1994: MLauritzen;

75

Acupuncture for patients with migraine: a randomized controlled trial.

2005: BBrinkhaus; MGHammes; AHoppe; SJürgens; KLinde; DMelchart; VPfaffenrath; AStreng; ... SWagenpfeil; WWeidenhammer; SNWillich; CWitt;

73

Migraine as a risk factor for subclinical brain lesions.

2004: JTBakkers; MDFerrari; PAHofman; MCKruit; LJLauner; GMTerwindt; MAVan Buchem;

71

The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease.

2011: JPDreier;

70

Epidemiology of headache in a general population--a prevalence study.

1991: RJensen; JOlesen; BKRasmussen; MSchroll;

69

An association between migraine and cutaneous allodynia.

2000: ZHBajwa; RBurstein; IGoor-Aryeh; BJRansil; DYarnitsky;

68

Brain stem activation in spontaneous human migraine attacks.

1995: HHCoenen; HCDiener; MJüptner; HKaube; VLimmroth; AMay; RVSchayck; CWeiller;

67

Neurobiology of migraine.

2003: DPietrobon; JStriessnig;

65